Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-06-09

Clinical Trial Update: Ranibizumab Treatment for Age-Related Macular Degeneretion [NA]

View source ↗

Summary

This document is a clinical trial update about using ranibizumab to treat age-related macular degeneration, with the study status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranibizumab (ranibizumab)

Snippet

Sponsor: Kyushu University | Conditions: Visual Disorder Due to Age-related Macula Degeneration | NA | Status: UNKNOWN